Lista de obras - Angiolo Gadducci - Dominio Público Uruguay

'Bat-like' choroid plexus and other sonographic features in trisomy 22 at the first trimester of pregnancy

artículo científico publicado en 2013

Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables

scientific article published on 19 January 2019

Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients

artículo científico publicado en 2014

Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study).

artículo científico publicado en 2014

Alternatives to risk-reducing surgery for ovarian cancer

artículo científico publicado en 2013

An Analysis of Approaches to the Management of Endometrial Cancer in North America: A CTF Study

artículo científico publicado en 1998

An analysis of approaches to the treatment of endometrial cancer in Western Europe: A CTF study

artículo científico publicado en 1995

An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimens.

artículo científico publicado en 2012

Analysis of Failures after Negative Second-Look in Patients with Advanced Ovarian Cancer: An Italian Multicenter Study

artículo científico publicado en 1998

Analysis of Treatment Failures and Survival of Patients With Uterine Papillary Serous Carcinoma: A Cooperation Task Force (CTF) Study

artículo científico publicado en 2012

Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.

artículo científico publicado en 2016

Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer

artículo científico publicado en 2008

Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.

artículo científico publicado en 2001

Antiangiogenic agents in advanced, persistent or recurrent endometrial cancer: a novel treatment option

artículo científico publicado en 2013

Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research

artículo científico

Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study

artículo científico publicado en 2009

Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer

artículo científico publicado en 1999

Biochemical prognostic factors and risk of relapses in patients with cervical cancer.

artículo científico publicado en 2007

Carcinosarcoma of the Uterus: A Clinicopathological Multicenter CTF Study

artículo científico publicado en 1997

Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva

artículo científico publicado en 2011

Combined evaluation of serum CA 125 and CAM 29 in patients with epithelial ovarian cancer

artículo científico publicado en 1992

Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients

artículo científico publicado en 2004

Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma

artículo científico publicado en 1994

Comparison of Tumor-Associated Trypsin Inhibitor (Tati) with Ca125 as a Marker for Diagnosis and Monitoring of Epithelial Ovarian Cancer ⬇️

artículo científico publicado el 1 de enero de 1991

Comparison of the initial surgical experience with robotic and laparoscopic myomectomy

artículo científico publicado en 2013

Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer

scientific article published on 01 December 2000

Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy: a review of the literature.

artículo científico publicado en 2005

Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer

artículo científico publicado en 2001

Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma

artículo científico publicado en 1987

Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions

scientific article published on 15 May 2007

Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis

artículo científico publicado en 2012

Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis?

artículo científico publicado en 2007

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis

artículo científico publicado en 2016

Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women

scientific article published on 01 April 1996

Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study

artículo científico publicado en 2018

Dose individualization can minimize nephrotoxicity due to carboplatin therapy in patients with ovarian cancer

artículo científico publicado en 2009

Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer

artículo científico publicado en 1994

Endometrial Stromal Sarcoma: Analysis of Treatment Failures and Survival

artículo científico publicado en 1996

Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer

artículo científico publicado en 1994

Evolving role of serum biomarkers in the management of ovarian cancer

artículo científico publicado en 2006

Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma

artículo científico publicado en 1998

Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton

artículo científico publicado en 2008

Fertility drug use and risk of ovarian tumors: a debated clinical challenge

artículo científico publicado en 2012

Fertility outcome of breast cancer and Hodgkin's lymphoma female survivors: a growing clinical challenge for gynecologists and oncologists

artículo científico

Follow-up strategies in gynecological oncology: searching appropriateness.

artículo científico publicado en 2007

Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study

scientific article published on 01 June 2002

Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma

artículo científico publicado en 2003

Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest

artículo científico publicado en 1997

Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature.

artículo científico publicado en 2008

Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest

scientific article published on 01 February 2000

Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).

artículo científico publicado en 2010

Is reduction in size pathognomonic of functional ovarian cysts?

artículo científico publicado en 2003

Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary?

artículo científico

Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study

artículo científico publicado en 2013

Management of borderline ovarian tumors: Results of an Italian multicenter study

artículo científico publicado en 2006

Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM)

scientific article published on 26 October 2020

Melanoma of the lower genital tract: Prognostic factors and treatment modalities

artículo científico publicado en 2018

Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours

artículo científico

Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.

artículo científico publicado en 2016

Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research

artículo científico publicado en 2014

Molecular target therapies in endometrial cancer: from the basic research to the clinic.

artículo científico publicado en 2008

Multimodality approach in extra cervical locally advanced cervical cancer: chemoradiation, surgery and intra-operative radiation therapy. A phase II trial

scientific article published on 01 May 2011

Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists

artículo científico publicado en 2017

New insights on the pathogenesis of ovarian carcinoma: molecular basis and clinical implications

artículo científico publicado en 2012

Novel insights on the malignant transformation of endometriosis into ovarian carcinoma

artículo científico publicado en 2014

Novel targeted therapies in epithelial ovarian cancer: from basic research to the clinic

artículo científico publicado en 2007

Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer.

artículo científico publicado en 2006

Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors

scientific article published on 01 November 2011

Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.

artículo científico publicado en 2012

Ovarian cancer: optimal chemotherapy in relapsed disease.

artículo científico publicado en 2000

Ovarian function and childbearing issues in breast cancer survivors.

artículo científico publicado en 2007

Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study).

artículo científico publicado en 2007

Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study).

artículo científico publicado en 2013

Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study

artículo científico publicado en 2000

Pharmacological treatment for uterine leiomyosarcomas

artículo científico publicado en 2014

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.

artículo científico publicado en 2003

Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.

artículo científico publicado en 2009

Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy

scientific article published on 30 April 2019

Polycystic ovary syndrome and gynecological cancers: is there a link?

artículo científico publicado en 2005

Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: results of a multicenter retrospective Italian study

artículo científico publicado en 2005

Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer

scientific article published on 01 July 1997

Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses

artículo científico publicado en 1996

Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer

artículo científico publicado en 2006

Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status

artículo científico publicado en 1993

Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinoma

artículo científico publicado en 1994

Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue

artículo científico publicado en 2009

Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.

artículo científico publicado en 2013

Prognostic factors in uterine sarcoma

artículo científico publicado en 2011

Prognostic role of bowel involvement in optimally cytoreduced advanced ovarian cancer: a retrospective study

artículo científico publicado en 2014

Prognostic role of immunosuppressive acidic protein in advanced ovarian cancer

artículo científico publicado en 1996

Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer

scientific article published on 01 May 1996

Relationship between time interval from primary surgery to the start of taxane- plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study.

artículo científico publicado en 2004

Renal impairment in patients with ovarian cancer

artículo científico publicado en 2003

Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia

artículo científico

Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9).

artículo científico publicado en 2014

Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study.

artículo científico publicado en 2013

Serum CA125 assay at the time of relapse has no prognostic relevance in patients undergoing chemotherapy for recurrent ovarian cancer: a multicenter Italian study

artículo científico publicado en 1997

Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study

artículo científico publicado en 1995

Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer

scientific article published on 01 August 1995

Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer

artículo científico publicado en 1998

Serum soluble interleukin-2 receptor assay in epithelial ovarian cancer

artículo científico publicado en 1993

Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological and experimental data.

artículo científico publicado en 2004

Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature

artículo científico publicado en 2011

Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A challenging question for gynecologic oncologists

artículo científico publicado en 2018

Squamous cell carcinoma of the vagina: natural history, treatment modalities and prognostic factors

artículo científico publicado en 2014

Surgical and Medical Treatment of Clear Cell Ovarian Cancer

artículo científico publicado en 2011

Surveillance of patients after initial treatment of ovarian cancer

scientific article published on July 2009

Surveillance procedures for patients treated for endometrial cancer: a review of the literature

artículo científico publicado en 2010

Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature.

artículo científico publicado en 2007

Surveillance procedures for patients with cervical carcinoma: a review of the literature.

artículo científico publicado en 2009

The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: A multicenter retrospective Italian study

artículo científico publicado en 2010

The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer

artículo científico publicado en 2001

The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients

artículo científico publicado en 1992

The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis

artículo científico publicado en 1992

The evolving role of adjuvant therapy in endometrial cancer

scientific article published on 24 April 2010

The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option

artículo científico publicado en 2009

The perioperative management of patients with gynaecological cancer undergoing major surgery: A debated clinical challenge

artículo científico publicado en 2009

The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma

artículo científico publicado en 2004

The relationship between postoperative decline of serum CA 125 levels and size of residual disease after initial surgery in patients with advanced ovarian cancer: a CTF study

artículo científico publicado en 1996

The role of HE4 in ovarian cancer follow-up: a review.

artículo científico publicado en 2014

The role of the French-Italian glossary of complications in the outcome evaluation of cervical cancer treatment: an Italian multicentric study.

artículo científico publicado en 2003

The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.

artículo científico publicado en 2007

The treatment of progressive ovarian carcinoma with D-Trp-LHRH (Decapeptyl). Gruppo Oncologico Nord ovest (GONO)

scientific article published on 01 January 1994

Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer

artículo científico publicado en 2010

Tissue biomarkers as prognostic variables of cervical cancer

artículo científico

Unilateral adnexal agenesis and dermoid cyst: fertility implications

artículo científico publicado en 2015

Uterine leiomyosarcoma: analysis of treatment failures and survival

artículo científico publicado en 1996

Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy.

artículo científico publicado en 2012

Weekly Low-Dose Paclitaxel as Maintenance Treatment in Patients With Advanced Ovarian Cancer Who Had Microscopic Residual Disease at Second-Look Surgery After 6 Cycles of Paclitaxel/Platinum-Based Chemotherapy

artículo científico publicado en 2009

Weekly epirubicin in the treatment of gestational breast cancer (GBC).

artículo científico publicado en 2008

Lista de obras de Angiolo Gadducci

'Bat-like' choroid plexus and other sonographic features in trisomy 22 at the first trimester of pregnancy

Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables

Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients

Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study).

Alternatives to risk-reducing surgery for ovarian cancer

An Analysis of Approaches to the Management of Endometrial Cancer in North America: A CTF Study

An analysis of approaches to the treatment of endometrial cancer in Western Europe: A CTF study

An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimens.

Analysis of Failures after Negative Second-Look in Patients with Advanced Ovarian Cancer: An Italian Multicenter Study

Analysis of Treatment Failures and Survival of Patients With Uterine Papillary Serous Carcinoma: A Cooperation Task Force (CTF) Study

Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.

Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer

Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.

Antiangiogenic agents in advanced, persistent or recurrent endometrial cancer: a novel treatment option

Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research

Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study

Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer

Biochemical prognostic factors and risk of relapses in patients with cervical cancer.

Carcinosarcoma of the Uterus: A Clinicopathological Multicenter CTF Study

Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva

Combined evaluation of serum CA 125 and CAM 29 in patients with epithelial ovarian cancer

Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients

Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma

Comparison of Tumor-Associated Trypsin Inhibitor (Tati) with Ca125 as a Marker for Diagnosis and Monitoring of Epithelial Ovarian Cancer ⬇️

Comparison of the initial surgical experience with robotic and laparoscopic myomectomy

Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer

Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy: a review of the literature.

Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer

Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma

Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions

Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis

Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis?

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis

Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women

Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study

Dose individualization can minimize nephrotoxicity due to carboplatin therapy in patients with ovarian cancer

Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer

Endometrial Stromal Sarcoma: Analysis of Treatment Failures and Survival

Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer

Evolving role of serum biomarkers in the management of ovarian cancer

Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma

Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton

Fertility drug use and risk of ovarian tumors: a debated clinical challenge

Fertility outcome of breast cancer and Hodgkin's lymphoma female survivors: a growing clinical challenge for gynecologists and oncologists

Follow-up strategies in gynecological oncology: searching appropriateness.

Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study

Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma

Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest

Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature.

Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest

Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).

Is reduction in size pathognomonic of functional ovarian cysts?

Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary?

Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study

Management of borderline ovarian tumors: Results of an Italian multicenter study

Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM)

Melanoma of the lower genital tract: Prognostic factors and treatment modalities

Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours

Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.

Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research

Molecular target therapies in endometrial cancer: from the basic research to the clinic.

Multimodality approach in extra cervical locally advanced cervical cancer: chemoradiation, surgery and intra-operative radiation therapy. A phase II trial

Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists

New insights on the pathogenesis of ovarian carcinoma: molecular basis and clinical implications

Novel insights on the malignant transformation of endometriosis into ovarian carcinoma

Novel targeted therapies in epithelial ovarian cancer: from basic research to the clinic

Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer.

Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors

Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.

Ovarian cancer: optimal chemotherapy in relapsed disease.

Ovarian function and childbearing issues in breast cancer survivors.

Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study).

Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study).

Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study

Pharmacological treatment for uterine leiomyosarcomas

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.

Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.

Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy

Polycystic ovary syndrome and gynecological cancers: is there a link?